Sonavex is committed to improving outcomes for surgical patients by using cutting-edge imaging technology to provide clinicians with visualization of critical data -- directly at the point of care.
June 2018 - Sonavex Received FDA 510(k) Clearance for EchoMark & EchoMark LP Tissue Markers Press Release
March 2018 - Sonavex Submits 510(k) Application to FDA, Dials Up Series A to $4.5M
April 2017 - Sonavex Closes Oversubscribed Series A, Adds Two Industry Veterans to Board Press Release
September 2016 - Sonavex awarded Phase II National Science Foundation Small Business Innovation Research Grant
June 2016 - Sonavex named 2016 Maryland Incubator Company of the Year Press Release